Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma
Open Access
- 7 June 2007
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 21 (10), 2227-2230
- https://doi.org/10.1038/sj.leu.2404780
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Absolute lymphocyte count predicts overall survival in follicular lymphomasBritish Journal of Haematology, 2006
- Absolute Lymphocyte Count Recovery Predicts Superior Survival and Is Independent of the International Prognostic Index in Patients Treated with CHOP or R-CHOP Chemotherapy for Diffuse Large B Cell Lymphoma.Blood, 2005
- Lymphocyte Count Persistence and Early Recovery Predicts Superior Survival and Is Independent of the International Prognostic Index in Patients Treated with CHOP Chemotherapy for Diffuse Large B Cell Lymphoma.Blood, 2004
- From the bench to the bedside: ways to improve rituximab efficacyBlood, 2004
- In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomasBlood, 2003
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993